These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25765509)

  • 41. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients.
    Api AM; Basketter DA; Cadby PA; Cano MF; Ellis G; Gerberick GF; Griem P; McNamee PM; Ryan CA; Safford R
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):3-23. PubMed ID: 18406028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation of the dermal sensitization Quantitative Risk Assessment (QRA) for fragrance ingredients.
    Api AM; Vey M
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):53-61. PubMed ID: 18635300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dermal sensitization threshold (DST) approach for mixtures evaluated as negative in in vitro test methods; mixture DST.
    Nishijo T; Miyazawa M; Saito K; Otsubo Y; Mizumachi H; Sakaguchi H
    J Toxicol Sci; 2019; 44(1):23-34. PubMed ID: 30626777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
    Griem P; Goebel C; Scheffler H
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantifying skin sensitization potency.
    Roberts DW
    Contact Dermatitis; 2012 Jun; 66(6):356-7. PubMed ID: 22568851
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of ethanol:diethylphthalate as a vehicle for the local lymph node assay.
    Betts CJ; Beresford L; Dearman RJ; Lalko J; Api AP; Kimber I
    Contact Dermatitis; 2007 Feb; 56(2):70-5. PubMed ID: 17244073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.
    Pemberton MA; Lohmann BS
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):467-75. PubMed ID: 24859074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An assessment of the skin sensitisation hazard of a group of polyfunctional silicones using a weight of evidence approach.
    Petry T; Bosch A; Coste X; Dupuis V; Eigler D; Germain P
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):305-14. PubMed ID: 22981813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach.
    Enoch SJ; Madden JC; Cronin MT
    SAR QSAR Environ Res; 2008; 19(5-6):555-78. PubMed ID: 18853302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential.
    Patlewicz G; Aptula AO; Uriarte E; Roberts DW; Kern PS; Gerberick GF; Kimber I; Dearman RJ; Ryan CA; Basketter DA
    SAR QSAR Environ Res; 2007; 18(5-6):515-41. PubMed ID: 17654336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the potency of respiratory allergens: uncertainties and challenges.
    Basketter DA; Kimber I
    Regul Toxicol Pharmacol; 2011 Dec; 61(3):365-72. PubMed ID: 22019813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification of chemicals as sensitisers based on new test methods.
    Botham PA
    Toxicol Lett; 1992 Dec; 64-65 Spec No():165-71. PubMed ID: 1471170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An epidermal equivalent assay for identification and ranking potency of contact sensitizers.
    Gibbs S; Corsini E; Spiekstra SW; Galbiati V; Fuchs HW; Degeorge G; Troese M; Hayden P; Deng W; Roggen E
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):529-41. PubMed ID: 23876969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
    Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
    Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimised testing strategies for skin sensitization--the LLNA and beyond.
    Basketter D; Crozier J; Hubesch B; Manou I; Mehling A; Scheel J
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):9-16. PubMed ID: 22713689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The regulatory use of the Local Lymph Node Assay for the notification of new chemicals in Europe.
    Angers-Loustau A; Tosti L; Casati S
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):300-7. PubMed ID: 21539884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.